SangStat Med. (SANG) - 10 of 10 analysts say Strong Buy Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SangStat Med. (SANG) - 10 of 10 analysts say Strong Buy

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John S. Sturges who wrote (71)	2/20/1998 4:03:00 PM
From: deadstrait	Read Replies (1) of 184

Well, it is past the 18th and it looks to me as if PDLI didn't do all that well on all this great news. Apparently, Zenapax is not the cure all that you claimed it would be. At least not many others seem to think it is and I believe that is reflected in PDLI price per share. Kinda went backwards since the 18th. I do notice that SANG has been very solid at 28 to 29. I also believe that those of us who are holding SANG long term are going to be reaping the benefits soon. Zenapax to eliminate the Cyclo market? HEHEHE, I don't think so. Nice try though. Dead

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next